Bashkortostan to develop mRNA technologies

Bashkortostan will become the first region in Russia with a full production cycle for mRNA drugs. The fifth session of the scientific and technical council of the mRNA Technologies Scientific and Technical Centre was held on the campus of Bashkir State Medical University.

The session focused on applying the technologies in oncology, infection prevention and cardiology, as well as developing infrastructure under the national project “Long and Active Life”. Acting Premier Alexander Sheldyayev highlighted the strategic role of Ufa and the region. He said the university joined the centre in February 2026 and was added to the list of medical organisations authorised to prepare and use individualised biotechnological drugs. The republic's government said it would support infrastructure development, interagency cooperation and personnel training.

The consortium includes 20 organisations, among them five Russian medical universities. Alexander Gintsburg, scientific head of the Gamaleya Research Center, said one of the main tasks is creating a national data centre with genetic information on oncology patients.